The company stated that the FDA noted at least one additional adequate and well controlled study to demonstrate a positive ...

Andrew G. Lee, MD, and Drew Carey, MD, return for this episode of 'NeuroOp Guru' to discuss how sixth nerve palsy with ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

In celebration of Ophthalmology Times 50th anniversary, we asked leading experts in the field what they see as the biggest ...

The May 4 event, themed around Star Wars, will feature the latest innovations, foster open discussions, and provide a ...

The approval makes ILM-Blue the first DORC posterior dye product available in China, according to a press release from Zeiss.

The decision to discontinue the trials comes shortly after the announcement that COAST missed its primary endpoint.

Pantheon Vision’s bioengineered corneal implant aims to tackle issues with the success rate of human donated tissue.

Labtician Ophthalmics has announced the commercial launch of Lab TRIACTIV, an artificial tear designed to redefine dry eye ...

Urcosimod (formerly known as OK-101) has been shown to be stable for over 2 and a half years in single-use ampoules used for administration of the drug to patients.

Epi-on corneal crosslinking is advancing through innovations like supplemental oxygen, chemical oxygenation, and ...